Brief report| Volume 40, ISSUE 6, P547-549, September 15, 1996

Intranasal oxytocin in obsessive-compulsive disorder

      This paper is only available as a PDF. To read, Please Download here.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association, Committee on Nomenclature and Statistics
        4th ed. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, New York1994
        • Anssean M
        • Legros JJ
        • Mormont C
        • et al.
        Intranasal oxytocin in obsessive compulsive disorder.
        Psychoneuroendocrinology. 1987; 12: 231-236
        • Bohus B
        • Kovacs GL
        • De Wied D
        Oxytocin, vasopressin and memory.
        Brain Res. 1978; 157: 414-417
        • Charles G
        • Guillaume R
        • Schittecatte M
        • Pholien P
        • Van Wettere JP
        • Wilmotte J
        Oxytocin in the treatment of obsessive-compulsive disorder: A report on two cases.
        Psychiatry Psychobiol. 1989; 4: 111-115
        • Den Boer JA
        • Westenberg HGM
        Oxytocin in obsessive compulsive disorder.
        Peptides. 1992; 13: 1083-1085
        • Epperson CN
        • McDougle CJ
        • Brown RM
        • Price LH
        Obsessive compulsive disorder during pregnancy and the puerperium.
        American Psychiatric Association New Rearch Abstract #NR112. 1995; (May 22): 84
        • Goodman WK
        • Price LH
        • Delgado PL
        • et al.
        Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder.
        Arch Gen Psychiatry. 1990; 47: 577-585
        • Insel TR
        Oxytocin—A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic and comparative studies.
        Psychoneuroendocrinology. 1992; 17: 3-35
        • Kaltwasser TM
        • Crawley JN
        Oxytocin and cholecystokinin induce grooming behavior in the ventral tegmentum of the rat.
        Brain Res. 1987; 426: 1-7
        • Leckman JF
        • Goodman WK
        • North WC
        • et al.
        The role of central oxytocin in obsessive compulsive disorder and related normal behavior.
        Psychoneuroendocrinology. 1994; 19: 723-749
        • Leckman JF
        • Goodman WK
        • North WC
        • et al.
        Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: Comparison with Tourette's syndrome and healthy controls.
        Arch Gen Psychiatry. 1994; 51: 782-792
        • Mazurek MF
        • Beal MF
        • Bird ED
        • Marin JB
        Oxytocin in alzheimer's disease: Postmortem brain levels.
        Neurology. 1987; 37: 1001-1003
        • Pedersen CA
        • Prange AJ
        Induction of maternal behaviour in virgin rats after intracerebroventricular administration of oxytocin.
        in: Proc Natl Acad Sci USA. 76. 1979: 6661-6665
        • Salzberg AD
        • Swedo SE
        Oxytocin and vasopressin in obsessive-compulsive disorder.
        Am J Psychiatry. 1992; 149: 713-714